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 6
 INTRODUCTION 
 Chronic suppurative otitis media and its complications are among 
one of the most common conditions seen by otorhinolaryngologist, 
pediatrician and general practitioner. It is disease of multiple etiology 
and is well known for its persistence and recurrence inspite of treatment. 
 Chronic suppurative otitis media is a long standing inflammation 
of the middle ear cleft. From early days of otology, it is divided into two 
clinical types. Tubotympanic and atticoantral disease. Tubotympanic 
disease is characterised by perforation in pars tensa. As it follows a 
more benign clinical course, term `safe' is applied to it, though it is not 
always true. It is called active when in addition to tympanic membrane 
defect, middle ear mucosa is inflammed and edematous with production 
of excess of mucus or mucopus. 
 Even with newer antibiotics being licenced for use almost every 
year, chronic suppurative otitis media largely remains unconquered and 
continues to be one of the major causes of otologic  morbidity. Its 
clinical significance is particularly related to its propensity to cause 
infectious complications as acute and chronic mastoiditis, petrositis, 
intracranial infections, and non-infectious sequel as chronic perforation 
of tympanic membrane, ossicular erosion, labyrinthine erosion, 
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tympanosclerosis, which are the major causes of hearing loss through 
out the world. 
 Management of CSOM begins with accurate documentation of 
tympanic membrane defect, preferably with operating microscope. 
Assessment of hearing loss by tuning fork test and pure tone audiometry 
is necessary as most of patients have associated conductive hearing loss. 
Appropriate therapy for otorrhea involves identification of offending 
organism by means of culture and sensitivity of middle ear discharge. 
 Almost all aspects of disease have been well studied over past few 
decades, but exhaustive review of available literature shows many 
authors focussed their attention primarily on bacterial flora, with 
comparatively fewer reports on mycological aspects, importance of 
which has been increasing in recent years because of excessive use of 
broad spectrum antibiotics, corticosteriods, and immune deficiency 
states. Number of Indian reports on this aspect have been meagre. 
 Causative bacterial flora and their sensitivity patterns are also 
subjected to change from time to time with emergence of multiple drug 
resistant strains. As for selection of first line therapy, it must be made by 
individual physician based on regional susceptibility data of bacterial 
pathogens. 
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 By this study an attempt is made to reevaluate the role of bacterial 
and fungal pathogens in CSOM, with regional antimicrobial  
susceptibility data, so as to suggest management guidelines based on 
these observations. 
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REVIEW OF LITERATURE 
Chronic suppurative otitis media is defined as the chronic or 
intermittent otorrhea through a persistent non-intact tympanic 
membrane.2 
Anatomy 
 Tympanic membrane – Correct form and structure of tympanic 
membrane was first described by Henry Johes Shrapnell in 1830.3 If 
forms partition between external auditory canal and middle ear. Shaped 
like an irregular cone, with apex being formed by umbo at tip of handle 
of malleus, a bright cone of light can be seen radiating from umbo to 
periphery in antero inferior quadrant. It is obliquely set, as a result, 
postero-superior part is more lateral than its antero inferior part. Adult 
tympanic membrane is 10mm tall, 8-9mm wide, and 0.1mm in 
thickness. Fibrous annulus anchors it in tympanic sulcus which is 
deficient superiorly at notch of Rivinus. 
 By anterior and posterior malleolar folds running from lateral 
process of malleus, it is divided into superior pars flaccida (Shrapnell's 
membrane) and inferior pars tensa. Shrapnell's membrane serve as 
lateral wall of Prussak's space (Superior recess of tympanic membrane). 
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 Tympanic membrane is a trilaminar structure, Lateral surface is 
lined  by squamous  epithelium, medial layer is continuous with 
mucosal layer of middle ear, between these two layer is the fibrous layer 
or pars propia. It is thin and not orderly organized in pars flaccida. 
Middle ear 
 Middle ear together with eustachian tube, aditus, antrum and 
mastoid air cells is called middle ear cleft. It is a sagitally oriented slit 
traversed by ossicular chain and lined by mucosal epithelium. Planes 
extending from tympanic annulus subdivide it into mesotympanum 
(lying opposite to pars tensa), epitympanum or  attic (lying above pars 
tensa but medial to Shrapnell's membrane and bony lateral attic wall) 
hypotympanum (below level of pars tensa). The portion of middle ear 
around tympanic orifice of eustachian tube is called protympanum. 
 Middle ear is likened to a six sided box with roof, floor, medial, 
lateral, anterior and posterior walls. 
 Anterior wall – Here, thin plate of bone separate cavity from 
internal carotid artery. Anterior wall is dominated by bulge of semicanal 
of tensor tympani muscle. Tympanic orifice of eustachian tube is 
immediately interior to this bulge. 
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 Posterior wall – Key feature is the pyramidal eminence and lateral 
to it is the chordal eminence. Aditus lies above the pyramid. Facial 
nerve runds in posterior wall just behind pyramid. Facial recess is the  
depression in the posterior wall lateral to pyramid. 
           Medical wall or surgical floor of middle ear- Presents a bulge 
called promontory due to basal coil of cochlea and 3 depressions; Sinus 
tympani, oval window niche and round window niche. Sinus tympani is 
defined by ponticulus superiorly, subiculum, inferiorly, mastoid 
segment of facial nerve laterally, and posterior semicircular canal 
medially. Oval window niche is anterior superior to ponticulus and is 
occupied by stapes foot plate. Above oval window is the canal for facial 
nerve and above it is the prominence of lateral semicircular canal. 
Round window niche found posteroinferior to promontory, being 
covered by secondary tympanic membrane. 
 Roof is formed by tegmen tympani separating tympani cavity 
from middle crucial from middle cranial fosse. 
          Floor is formed by thin plate of bone which separate tympanic 
cavity from jugular bulb. 
         Ossicles- They conduct round energy from tympanic membrane to 
oval window. They are, 
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 Malleus – Has head, neck, handle, anterior and lateral processes. 
Head and neck lies in attic. Axis of rotation is along anterior ligament of 
malleus. 
 Incus – Has body and three processes  Long, short and lenticular. 
Body articulates with head of malleus. Short process is anchored to 
incudal fossa. Long process extends inferiorly terminating at lenticular 
process which aritulates with head of stapes. It is prone to osteitic 
resorption owning to tenuous blood supply in face of chronic 
suppurative otitis media. 
 Stapes – It has head, neck, anterior, posterior crura and foot plate. 
Foot plate sits in the oval window. 
 Intra tympanic muscles – Tensor tympani and stapedius. They 
help to dampen very loud sounds thus preventing noise trauma. 
 Histology – Cilliated pseudostratified columar epithelium of 
respiratory tract extend up the eustachian tube as far as anterior part of 
middle car cavity. They are capable of producing mucus. More 
posteriorly mucosa changes to simple cubodial or stratified epithelium 
with no secretory elements. Medial aspect of  tympanic membrane and 
mastoid air cells are lined by single layer of cells ranging from cuboidal 
to flat in shape. 
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Physiology of hearing 
 The purpose of auditory apparatus is to convert air borne 
vibrations to vibrations in inner ear fluids and then to nerve impulses to 
be transmitted to higher centers of hearing. 
 To over come impedance offered by inner ear fluids, sound 
energy of greater amplitude and less force need to get converted to 
lesser amplitude and greater force. It is achieved by impedance 
matching or transformer action of middle ear, accomplished by 
hydraulic action of tympanic membrane, lever action of ossicles and 
curved membrane effect., together giving total transformer ratio of 18:1. 
Phase differential between oval window and round window need to be 
maintained for normal hearing. It's is by preferential conduction to oval 
window by intact tympanic membrane and ossicles. Eustachian tube 
maintains equal pressures on either side of tympanic membrane for its 
efficient functioning. Transduction of mechanical energy to electrical 
impulses is at the level of organ of corti. Conduction of these electrical 
impulses to brain is via cochlear nerve to auditory nuclei in brain stem 
and from there to auditory cortex where these impulses are perceived as 
sound. 
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Epidemiology 
 Prevalence of CSOM varies between racial and socio economic 
groups. It is extremely common in native American Indian, Canadian 
and Alaskan inuits, Australian aborigines and New Zealand Maoris.2 In 
U.K. prevalence is 0.6% of adult population. (Browing – 1982).4 In 
India, overall prevalence rate is 46 and 16 persons per thousand in rural 
and urban population respectively.5 High prevalence in developing 
countries is due to adverse socioeconomic status, poor housing with 
damp and over crowded living quarters and limited access to medical 
care.2 
Classification 
 A. Anatomical 
 a. Tubotympanic b. Atticoantral  
 Tubotympanic disease is characterised by perforation in pars 
tensa. They are not generally considered to be at risk of developing 
serious complications. So term `safe' ear used. But Browing6 (1984) 
pointed out that mucosal disease unassociated with cholesteatoma can 
have significant morbidity including mastoiditis, otitic hydrocephalus, 
lateral sinus thrombosis, extradural abscess, meningitis, brain abscess, 
petrositis, labyrinthitis and facial paralysis. 
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 Atticoantral disease commonly involves pars flaccida and is 
characterized by formation of a retraction pocket in which keratin 
accumulate to produce cholesteatoma. Marginal perforations are also 
considered sinister because they may go in for cholesteatoma. 
b. Pathological Classification7 
a. Inactive (Mucosal) chronic otitis media.  
There is a permanent defect of pars tensa, but no current evidence 
of inflammation either in middle ear mucosa or tympanic 
membrane. Ossicular chain may be eroded or fixed. The natural 
history of such an ear is to become active or remain inactive. 
b. Active (Mucosal) Chronic Otitis Media 
 In addition to tympanic membrane defect, the middle ear mucosa 
is inflamed and edematous with production of excess mucus or 
mucopus. Such activity may be continuous or intermittent. In 
some cases, granulations or polyp may develop. 
c. Active Squamous epithelial Chronic Otitis Media                       
Cholesteatoma 
 Here, along with active mucosal otitis, there is squamous 
epithelial lined pocket full of squamous epithelial and 
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inflammatory debries. This most frequently occurs in pars 
flaccida but can occur from pars tensa retraction pocket also. 
d. Inactive squamous epithelial chronic otitis media 
Retraction Pocket 
 It is the pars flaccid or pars tensa retraction, a part of which is out 
of vision to otoscopist which is considered abnormal because of 
potential to retain squamous debris, which may lead to 
cholesteatoma. 
c. Clinical Classification 
 Thorburn8 (1965) described tubotympanic disease into two types. 
1. Permanent perforation syndrome.. LILLIE type I. 
 This consists of persistent perforation of tympanic membrane 
involving pars tensa. Margins of perforation are covered with healed 
epithelium. The ear may be completely dry for a long period or it may 
discharge intermittently. Such discharge may be caused by infected 
water passing through external canal or may spread up from Eustachian 
tube from nose blowing or sneezing., facilitated by air readily passing 
outward through perforation. In the dry state, tympanic membrane is 
pink and granulations or debris are not present in the tympanum. When 
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such an ear discharges secretions are mucoid or mucopurulent and may 
be very profuse. There is no odour to the discharge The mucosa in the 
tympanum becomes red and oedematous. 
d. Chronic Tubotympanic Mucositis. LILLIE type II. 
 As the term implies, the ear presents a long standing infection 
characterized by an odourless mucoid or mucopurulent discharge which 
becomes very profuse and is associated with upper respiratory tract 
infection A large and often near total defect of tympanic membrane is 
usually present Only the limbus may persist. A shortened malleus may 
be present The exposed mucosa on the promontory is markedly 
thickened and red. The exposed ossicles are buried in this thick 
exuberant and edematous mucosa. Polyps may be present as a result of 
marked swelling of tympanic mucosa and these polyps may be 
associated with necrosis of ossicles or underlying portion of temporal 
bone. 
 In some of these cases, after a long period of suppuration, there is 
in growth of epithelium around perforation margins and into posterior 
tympanum or attic producing a secondary cholesteatoma. Such a case is 
classified as Lillie type III. 
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Types of Perforation 
 Described according to their anatomical location.2 
 Central perforations – located in par tensa and are surrounded by 
some residual tympanic membrane. 
 According to their location in relation to handle of malleus, they 
can be anterior, posterior or inferior 
 A subtotal perforation is a large defect surrounded by a 
completely intact annulus. 
 Marginal perforation is usually in the posterior part of tympanic 
membrane with pathological loss of annulus allowing direct exposure of 
the bony canal wall. 
 Attic perforation is the defect in pars flaccida. 
Ethiopathogenesis 
1. Environmental 
 As with any other medical illness – CSOM correlates with 
socioeconomic status, with lower groups having higher incidence. It is 
related to general health, diet and overcrowding at home. 
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2. Genetic 
 Mastoid air cell system is smaller in individuals with otitis media. 
The degree of initial mastoid aeration may be a predisposing factor, but 
once the condition developed cell system will decrease in size. 
3. Previous otitis media 
 In majority of cases, CSOM occurs as a consequence of an 
episode of acute suppurative otitis media with perforation with 
subsequent failure of perforation to heal. Also it can be a sequel of otitis 
media with effusion as here, chronic retraction of tympanic membrane 
causes loss of fibrous layer. (Smyth 1980)9 which will not heal if there is 
a subsequent perforation9 
4. Infective 
 Bacteria are almost invariably isolated, but they may be 
secondary invaders of a mucosa which is inflammed because of other 
factor., but they can perpetuate the process as they can produce 
substances that affect cilliary function (Wilson & Colle 1988)10 
5. Upper respiratory tract infection 
 A reasonable postulate is that if one area of respiratory mucosa is 
affected, there is an increased likelihood that another part will also be 
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affected, as many patients state that their ear start to discharge after an 
upper respiratory tract infection. 
6. Auto immunity 
 It is likely that individuals with established auto immune disease 
will have higher incidence of CSOM, but only rheumatoid arthritis been 
proved till date. (Camilleri et al 1992).11 
7. Allergy 
 Allergic individuals have higher incidence of CSOM. Also allergy 
to topical antibiotics, or bacteria and their toxins may contribute to 
CSOM. 
8. Eustachian  Tube Malfunction 
 Abnormal Eustachian tube function associated with cleft palate, 
Down's syndrome, patulous eustachian tube predispose to CSOM. 
9. Trauma 
 Iatrogenic (following grommet insertion) & Traumatic perforation 
which is large and infected may fail to heal causing CSOM. 
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Pathology 
 Inactive chronic otitis media  - consistent finding is the loss of 
fibrous layer. So even if there is healing membrane bridging the defect 
is only an outer layer of squamous epithelium and inner mucosal layer. 
When perforation ins present, outer squamous epithelium  meets middle 
ear mucosa at variable points.  
 In active mucosal disease, non secretory middle ear mucosa is 
replaced by respiratory type mucus secreting mucosa with goblet cells. 
Mucosa is hyperemic with underlying inflammatory response. Mastoid 
mucosa seldom undergoes metaplasia to secretory lining. Granulation 
tissue is more common here. 
Clinical features 
 Two classic symptoms of CSOM are aural discharge and hearing 
loss. 
 Aural discharge of tubo tympanic disease in typically profuse, 
character varies form serous to mucous to frankly purulent. It is 
frequently intermittent, with increase in discharge associated with upper 
respiratory tract infection or contamination from external canal after 
bathing or Swimming, but can be continuous also May be blood stained 
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if there is associated aural polyps or granulations. Very rarely only it is 
foul smelling. 
 Hearing loss is usually conductive type, degree of which is 
influenced by, 
a. Size and position of perforation Larger perforation – More 
hearing loss Posterior perforation – More severe loss because 
of reduction of round window baffle effect. Small anterior 
defect, offen produce no impairment of hearing at all. 
b. Impairment of ossicular chain mobility either by ossicular 
necrosis or fixation.  
c. Presence of middle ear pathology as edema and granulation 
tissue. 
Paparella et al (1984)12 pointed out a definite increase in 
incidence of sensory neural hearing loss, mainly in high frequencies, 
owning to diffusion of bacterial toxins across round window membrane 
to cochlea. 
Pain is not a usual feature. Its presence should alert physician to 
possibility of more invasive pathology as with development of 
headache, vertigo and facial palsy. Features of secondary otitis externa 
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as itching, tragal tenderness, excoriation of external canal can be present 
with long standing profuse otorrhea. 
Examination 
1. Scars of previous ear surgery should be looked for on either 
side of pinna. 
2. Otomicroscopic examination need to be done in all cases and 
findings documented. Critical screening of the following areas 
need to be done. 
a. External auditory canal, ear drum Carefully cleaned off 
wax, debris which prevent complete visualization of 
tympanic membrane. 
b. All four quadrants of pars tensa observed carefully and size 
and location of perforation noted. 
c. Presence of squamous epithelium in middle ear is 
documented. 
d. Status of middle ear mucosa is assessed through 
perforation. Other middle ear structures that may be 
visualized are Eustachian tube orifice, Promontory, round 
window and oval window niche. 
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e. Presence and location of granulation or polyps documented. 
f. Integrity of ossicular chain as seen through perforation 
recorded. ie. any disruption of incudostapedial joint, 
necrosis of long process of incus, or foreshortening of 
handle of malleus. 
3. An assessment of hearing loss done by standard Rinnie and 
weber tuning fork tests. 
4. Nose and throat examined for focal sepsis if any. 
5. General physical examination done to rule out systemic causes 
leading to persistence of CSOM. 
Predisposing factors which lead to chronicity and recurrence of 
CSOM. 
A. LOCAL 
1. In ear 
a. Persistent perforation of tympanic membrane leading to bacterial 
contamination directly from external ear. Also loss of middle ear 
"gas cushion" which helps to prevent reflux of nasopharyngeal 
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secretions into middle ear via Eustachian  tube causes increased 
exposure of middle ear to pathogenic baceria from nasopharynx.13  
b. Involvement of middle ear with squmous metaplasia and other 
irreversible pathologies.  
c. Persistent obstruction to aeration of middle ear and mastoid air 
spaces caused by scarring, thickening of mucosa, polyps, 
granulations and tympanosclerosis.  
d. Areas of sequestration or persistent osteomyelitis in mastoid.  
2.  In nose and throat 
 a. Eustachian tube dysfunction 
 b. Chronic rhinitis / allergic rhinitis 
 c. Atropic rhinitis.  
 d. Sinusitis 
 e. Adenoditis, chronic tonsillitis, pharyngitis  
 f. Nasal Polyposis. 
 g. chronic granulomatous disease of nose and paranasal 
sinuses.  
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B. SYSTEMIC 
 Diabetes mellitus, tuberculosis, allergic disorder, renal diseases, 
adrenal cortical insufficiency, chronic leukemia, chronic liver diseases, 
wegners  granulomatosis, histocytosis X, dietary deficiencies, debility, 
agammaglobulinemia AIDS. 
 These conditions need to be adequately managed to obtain 
satisfactory  results for medical and surgical treatment of CSOM.  
Management 
 Swab from discharge should be sent for culture and sensitivity 
preferably prior to beginning of antimicrobial therapy. Audiologic 
evaluation is necessary as majority of patients will have conductive 
hearing loss Radiological examination is not necessary in uncomplicated 
cases of chronic suppurative otitis media with out cholesteatoma2. 
Microbiology 
 In normal individuals with intact tympanic membrane, culture 
swabs taken from middle ear mucosa will not grow any bacteria. In 
some, however upper respiratory tract flora as streptococci and 
pneumococci species may be isolated.  
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 When tympanic membrane defect is present, and if the mucosa is 
already inflammed secondary bacterial colonisation occurs.14  A wide 
range of organisms, both aerobic and anaerobic may be isolated, 
proportion of different organisms vary from study to study.  
 Morgagni was the first to describe suppuration in ear as a primary 
lesion. Andina and Aliman in 1950 stated in their work on importance 
of testing the resistance of  pathogenic bacteria and their sensitivity.15  
Collection of culture specimen 
 Special techniques, and procedures for improving bacterial 
isolation described. Materials available for culture are otorrhea, middle 
ear mucosa and mastoid portion of temporal bone.  
4. Otorrhea 
 Conventional method is by inserting sterile cotton tip in an 
applicator in external canal. This technique is inadequate as tip of the 
applicator cannot reach focus of infection in the middle ear. So sample 
get contaminated with discharge collected in external canal.16 But  
Raju K.G. et al. (1990)17  got identical results with culture obtained  
from middle ear and conventional external ear swab.  
 29 
 A nichrome wire loop has been used as another technique.16 But it 
has  disadvantages, as specimen collected should be immediately 
inoculated into medium and is not suitable for transport and anaerobic 
culture as it dries up.  
 Aspiration through perforation of tympanic membrane with 2ml 
disposable syringe fitted with 24 G needle or 18 G needle with plastic 
cannula also described16 but it is dangerous as it may injure middle ear. 
Further discharge may sometimes be inadequate to be aspirated to 
syringe.  
 If perforation is blocked by dry secretions or blood or 
granulations, or if tympanic membrane appears to be intact, culture of 
middle ear fluid can be obtained by tympanocentesis.  
 For higher yield of anaerobes, Induharan et al.  (1996)16 
recommended pre reduced 28 G nichrome wire swab which they  claim 
to be safe, simple and effective alternative  to commercially available 
transport media.  
2. Middle ear mucosa 
 Biopsy of middle ear mucosa may be desirable especially if there 
is large perforation of tympanic membrane or if patient undergoing 
exploratory tympanotomy or mastoidectomy. It provides a pathology 
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specimen and actual piece of infected tissue which may provide accurate 
microbiologic diagnosis than possibly contaminated secretion obtained 
from perforation. 18 
3. Mastoid portion of temporal bone 
 Since  CSOM involves mucosal lining of mastoid and possibly 
periosteum as well, biopsy of mastoid bone performed during 
mastoidectomy provides diseased tissue for culture and 
histopathological examination. In certain cases, it  may be appropriate to 
obtain needle aspiration of mastoid rather than open biopsy.18 
 Although several different organisms cultured, role of bacteria is 
often questioned as Picozzi et al (1982)19 pointed out nearly 50% of ears 
with inactive CSOM, identical bacterial flora as that of active ears is 
cultured. But it is proven that bacteria can produce substances which 
affect cilliary function. There is also evidence that poly microbial 
infection is more  damaging than monomicrobial infections.  
(Brook 1987).20 
 Most common aerobic organisms isolated are, pseudomonas 
aeruginosa,  staphylococcus aureus, proteus and Klebsiella, but their 
proportions vary from study to study. Staphylococcus aureus 
predominance was seen in various studies.21,22 In study by B.N.Rao et al 
(1994)23 Staphylococcus aureus was the  predominant species (42.5%) 
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followed by pseudomonas aeruginosa. (21.6%) Pseudomonas was most 
common isolate in studies by  R.D. Kulkarni et al (1993)24,  
Fliss D.M. et al (1992)25, Khanna et al (2000)26, Attallah M.S. (2000)27, 
Induharau R (1999)28, Aslam MA.. et al (2004)29. 
 Saini S et al (2005)30 concluded in their study that staphylococcus 
aureus was the commonest isolate in paediatric age group and 
pseudomonas aeruginosa in adults. A study on bacterial culture from 
mastoid granulations by Albert R.R et al (2005)31 found these 
granulations harbour polymicrobial pathogens, predominant aerobic 
isolates being coagulase negative  staphylococci, pseudomonas 
aeruginosa, staphylococcus aureus and non-fermenting gram negative 
bacteria suggesting these organisms may be responsible for granulation.  
 A review of aerobic isolates in different studies 
Year Author Pseudomonas Staphylococcus Proteus Klebsiella 
1992 Fliss DM25  84% 20% 15% 8% 
1994 M. Rao23 21.6% 42.5% 18.3% - 
1995 Obi CL 22 19.3% 33.6% 17% 4.3% 
1997 Ashok Mittal32 48.7% 22% 3% 2% 
1999 R. Induharan 28 27.2% 23.6% 12% - 
2000 Attallah M.S. 27 51% 31% 17% - 
2004 Aslam M.A.29 50.5% 23.6% 12% - 
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 Contrary to earlier opinion that type of flora are no different if 
cholesteatoma is present (Sweeny, Picozzi and Browning 1982).14 
Vartiainen E (1996)33 observed staphylococcus aureus was isolated in 
cholesteatoma ears more frequently than pseudomonas aeruginosa and 
in chronic ears without cholesteatoma, situation is reversed. He also 
observed bacteriological findings had no significant effect on incidence 
of complications caused by disease. Failure after surgical treatment were 
more common in pseudomonas ears.  
Perhaps most exciting development in field of microbial flora of 
CSOM in recent years is the discovery of presence of non-sporing 
anaerobes, but its actual role in disease causation is a subject of 
speculation. Bacteroids melaninogenicus, bacteroids fragilis and other 
speces were isolated from 30-50% cases.7 According to Sugita et al 
(1981)34 they were most frequently isolated in ears with extensive 
cholesteatoma and granulation tissue formation. Kelly (1978)35 
demonstrated combination of aerobic and anaerobic organisms produce 
more marked inflammatory response than same organisms alone in 
animal model. Heinemann (1963)36 a reported high incidence of 
anaerobes in otogenic intracranial infections. Indian literature shows 
30% R.D. Kulkarni et al (1993)24  51.6% Beena Antony et al (1996)37 
of anaerobic isolates.  
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Fungal infections in CSOM was noted as early as in 1967 by 
Larine et al.38 Some cases of tubotympanic disease keep on discharging 
inspite of topical antibiotic ear drops or systemic antibiotics.  
Sen Gupta et al (1978)39 proposed this intractable otorrhea to 
superimposed fungal infections over CSOM. 
Fungal spores ubiquitously found in atmosphere readily establish 
themselves in warm and moist environment of middle ear, their growth 
being favoured by presence of epithelial debries along with long term 
use of topical antibiotics. Humidity in ears with CSOM found is 
significantly higher than normal ears40 which aggravate the condition. 
Prevalence of fungal infection also varies between studies. 
 
Year Author % of fungi 
1978 Sen Gupta39 25% 
1992 Dincer A.D.21 28.6% 
1994 B.N. Rao23 7.5% 
1997 Ashok Mittal32 40.8% 
1997 Ibekwe A.O41 25% 
1998 Urmil Mohan42 13.7% 
2000 Khanna .V26 9% 
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Most common fungal species implicated was aspergillus 
flavus.26,32,39 But B.N.Rao,23 and Urmil Mohan42 reported candida as 
most common species. Tiwari.S (1995)43 reported a case of pure fungal 
bilateral chronic suppurative otitis media caused by Aspergillus terreus 
which responded well to topical ketoconazole therapy. Albertt R 
(2005)31 in their study on mastoid granulation reported single isolate of 
Aspergillus grown from granulation among total 79 cases. Martin T.J 
(2005)44 in a retrospective review on fungal causes of tympanostomy 
tube otorrhoea observed an increase in incidence of fungal infections 
after period of widespread use of fluroquinolone antibiotics. 
A 16 years retrospective analysis (from 1978 to 1991) on 
changing pattern of bacterial isolates and their sensitivities  
(Nakagawa T. et al, 1994)45 revealed a gradual rise in incidence of 
staphylococcus aureus infections while proteus infections gradually 
declined. Glucose non-fermenting gram negative rods, fungi and 
anaerobic bacteria increased during same period. 
Latest development in field of microbiology of CSOM is 
demonstration of  biofilms. Biofilms are "aggregated bacteria usually 
adherent to a surface, surrounded by an extra cellular matrix". They are 
recalcitrant to antibiotic treatment even though isolated bacteria are 
susceptible to antibiotics. Best studied pathogen for its propensity to 
form biofilm in pseudomonas aeruginosa. Biofilm associated 
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microorganisms are implicated in causation of, native valve 
endocarditis, infections associated with indwelling medical devices, 
chronic prostatitis as well as chronic otitis media. Dohar J.E. et al 
(2005)46 demonstrated pseudomonas aeruginosa biofilm in middle ear in 
CSOM by scanning electron microscopy in monkeys. Further research 
regarding role of biofilms  in antimicrobial resistance, chronic infections 
and as reservoir to pathogenic organisms is in progress. 
Treatment 
 Treatment goals of uncomplicated CSOM are to eliminate 
infection, prevent further infection, and to restore normal function of 
middle ear. Both medical and surgical interventions play their role in 
achieving these aims. 
Medical management 
 Three components of medical management are aural toileting, 
topical antibiotics and systemic antibiotics. 
Aural toilet 
 It is important for successful treatment of CSOM, particularly 
when topical medications are used. Cleaning the discharge from external 
auditory canal will allow the topical agent to reach the middle ear in 
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adequate concentration. In a controlled trial on medical management of 
active CSOM G.G.Browning et al47 reported efficiency of treating 
actively discharging tubotympanic disease with aural suctioning alone is 
almost same as using aural toileting along with gentamicin . However, 
sample size of this study was very small and hence results were not 
statistically significant. 
Methods 
1. Cotton buds – self cleaning of ear by dry mopping with self 
made cotton buds is a convenient method for dealing with 
active discharge. 
2. Syringing – Clearing debries and inflammatory exudate by 
syringing using normal saline at body temperature was 
recommended by Chui in 1982 and John Abramson 1984. 
Syringing of infected ear is not widely practiced 
nowadays.48 
3. Suction, aspiration and debridement of inflammatory 
exudates under operating microscope is probably the most 
popular method Magnification offered by microscope aids 
in assessing size, site of tympanic membrane defect, extent 
and type of pathological changes, evidences of destructive 
disease in ossicular chain and presence of sequel of chronic 
 37 
ear disease. It can be carried out at outpatient clinic either 
at weekly intervals103 or daily as preoperative regimen. 
Preoperative conservative treatment has been shown to 
decrease significantly the number of culture positive ears 
prior to surgery.48 
2. Topical antimicrobial therapy 
 Ototopical agents commonly used in treatment of CSOM are 
gentamicin, Neomycin, polymyxin B, and ciprofloxacin with or without 
steroids. 
 Although ototoxicity with aminoglycoside antibiotics has been 
demonstrated in animal model, there is no evidence that they cause 
sensory neural hearing loss in patients with CSOM (Fairbanks 1981).49 
This may be due to combination of factors, as relatively low 
concentration of aminoglycosides reaching middle ear because of 
oedema of mucosa, which prevents  direct absorption and also as human 
round window niche is deep and protected by pseudomembrane, less is 
the chance of ototoxicity with aminoglycosides in CSOM patients.13 
 Recent trials demonstrate increased efficacy and safety of 
fluroquinolone topical preparations like ciprofloxacin and ofloxacin 
over conventional polymyxin B, neomycin with or without 
hydrocortisone50,51 and topical gentamicin.52 A prospective observational 
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study on optimum duration of topical ofloxacin treatment53 advise two 
weeks course from aspect of bacteriologic efficacy, although patients 
showing insufficient symptomatic improvement after 2 wk may benefit 
from another one to two weeks of therapy. Administration upto 4 weeks 
can increase clinical efficacy without causing safety problems. Drug 
concentration analysis54. With 0.3% ofloxacin shows high concentration 
in otorrhea, very low or not detected in serum, and highly variable 
middle ear mucosal concentrations. It shows invariably drug reaches 
infection site. An article of concern is by Jang CH (2004)55 with report 
of ciprofloxacin resistant pseudomonas aeruginosa increasing recently. 
A meta analysis on effectiveness of 0.3% ofloxacin otic solution  
(Abes G et al 2003)56 conclude that ofloxacin otic ear drops is better 
than other antibiotic ear drops and other oral antibiotics in terms of 
overall cure rate.  
 It is conventional to use antibiotic steroid combination ear drops, 
but advantage of steroid combination has not been substantiated. 
Induharan et al (2005)57 in their comparative study with gentamicin or 
gentamicin steroid combination ear drops for three weeks, found no 
difference in clinical and bacteriological improvement or ototoxicity 
with or without steroids.  
 Other preparation used as ototopical agents are,  
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 1.5% acetic acid irrigation (one part of white vinegar in two parts 
water) at body temperature three times daily. Acetic acid irrigation 
removes accumulated debries and acidifies external canal, 
discouraging growth of pseudomonas and other bacteria.58 
 Burrow’s solution (13% aluminum acetate)  has been used since 
late 19 century. It is effective in vitro in inhibition of growth of 
commonly occurring organism in CSOM.59 
 Topical povidone iodine was compared to topical ciprofloxacin 
by Jaya et al (2003).60 They reported equal results with superior 
advantage of no invitro drug resistance and reduced cost of 
therapy for povidone. 
Systemic antibiotics 
 Success of antibiotic therapy is based upon conveyance of 
antibiotic to the site of bacterial activity in adequate concentration for 
adequate length of time. Unfortunately, fibrotic changes in chronic 
infection tend to isolate pockets of infection from effective blood supply 
so that systemic antibiotic therapy has been found disappointing in 
CSOM. 
 Because primary pathogen responsible is pseudomonas 
aeruginosa, choice of oral antibiotics are limited. Both ciprofloxacin and 
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Ofloxacin has good antipseudomonal activity. As per study by  
Gehauno P 1997.61 Oral ciprofloxacin is an effective and well tolerated 
treatment for CSOM in adults. But these are not recommended in 
children due to possibility of causing arthropathies. So for children, 
choice is limited to broad spectrum pencillins and they need to be 
administered parentally. 
 Another topic of controversy is treatment for anaerobic bacteria. 
Browing et. al (1983)62 pointed out that elimination of anaerobic 
bacteria from active ears does not render them inactive.  
 But superiority of therapy against anaerobes with clindamycin is 
illustrated by Brook I (1994).63 
Following factors account for disappointing results of antimicrobial 
therapy in CSOM, particularly in diffuse mucosal disease involving 
mastoid bowl and middle ear cavity. 
1. Poor drainage of inflammatory exudates. 
2. Presence of destructive disease associated with osteitis, 
granulations and polyp. 
3. Lack of information on efficacy of antimicrobial therapy in 
CSOM based on large scale controlled trials. 
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4. Presence of keratinizing squamous epithelium in middle ear. 
5. Presence of mixed aerobic, anaerobic flora and their 
pathological synergy. 
6. Possibility of infection with different strain of same species.  
7. Possibility that certain strains have particular virulence in 
relation to chronically diseased ear. 
8. Mucosal changes in active CSOM particularly in patients with 
long history of disease, characterized by subepithelial scarring 
and devasularisation both of which predispose to poor mucosal 
concentration of antimicrobial agent.  
9. Presence of debries and inflammatory exudates in middle ear 
prevents topical antibiotic from acting on organism. 
10. Resistant organisms. 
11. Local and systemic predisposing factors. 
Factors associated with susceptibility to complications were 
determined prospectively by Panda N.K. et al 1996.64 As per them, 
complications are more likely in patients younger than 15 years, with 
short history of ear discharge, in patients whom anaerobic organisms 
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isolated in culture and in patients with granulation tissue found at 
surgery. 
Surgical Treatment  
 If otorrhea recur or persist despite medical treatment, or if the 
patient feel handicapped by the residual conductive hearing loss, 
surgical therapy should be considered.  
1. Tympanoplasty 
 Ideally, surgery should be carried out when infection has been 
adequately treated and middle ear mucosa is healthy, as chance of 
successful outcome is increased. In this situation, a tympanoplasty with 
repair of tympamnic membrane and ossicular chain is recommended. 
2. Tympanomastoid surgery  
 In cases refractory to medical treatment, tympanoplasty combined 
with cortical mastiodectomy  is indicated. Aims of this procedure are to 
aerate middle ear and mastoid, remove chronically inflamed tissue, 
repair the tympanic membrane defect, and reconstruct ossicular chain. 
The achievement of all there goals often require more than are 
procedure in different sittings. 
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AIMS AND OBJECTIVES 
This study was conducted with following objectives: 
1. To study clinical profile of active tubotympanic chronic otitis 
media cases at upgraded Institute of otorhinolaryngology, 
Chennai. 
2. To asses prevalence and distribution of bacterial and fungal 
organisms in CSOM. 
3. To analyze antibiotic sensitivity and resistance pattern of bacterial 
isolates causing Chronic Suppurative Otitis Media (CSOM). 
4. To suggest practical recommendations based on the observations. 
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MATERIALS AND METHODS 
Study design 
 Hospital based clinical observational study. 
Setting 
 ENT out patient division of Upgraded Institute of 
otorhinolaryngology, Madras Medical College and Government General 
Hospital, Chennai. 
Duration 
 Specimen collection and analysis 1st January 2006 to 30th June 
2006. 
 Evaluation and data interpretation 1st July 2006 to 30th September 
2006. 
Sample case selection 
 100 cases of active Tubotympanic Chronic Suppurative Otitis 
Media by systemic random sampling method. 
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Inclusion criteria 
 1. Adult patients with active tubotympanic type of CSOM i.e. 
Chronic (more than 3 months) continous  or intermittent otorrhea 
through permanent defect in parstensa, with inflammed and edematous 
middle ear mucosa producing excess mucus or mucopus. 
2. Perforation should be moderate / large sized. 
3. History of partial or no response to prior treatment with 
commonly used ototopical agents like gentamicin, Neomycin, 
Polymyxin, Ciprofloxacin, before consultation. 
Exclusion criteria 
1. Pediatric age group – less than 15 yrs. 
2. Clinically unsafe ears – i.e. with cholesteatoma granulations or 
aural polyps. 
3. Overt clinical evidence of otitis externa with CSOM i.e external 
canal congested, inflammed, with otomycotic debries, Tragal 
tenderness. 
4. Discharging ear through a pin hole perforation. 
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5. Cases undergone previous ear surgeries. 
6. Suspected complications of CSOM. 
7. Patients with clinical evidence of chronic sinusitis chronic 
tonsillitis. 
8. Known or treated cases of pulmonary tuberculosis. 
9. Known immune deficiency states – Diabetes mellitus, AIDS, 
renal diseases, bronchectasis. 
 All patients evaluated by detailed history and examination. 
Initially, collected discharge in external canal was cleaned by dry 
mopping method using sterile cotton wool tipped applicators. Otoscopic 
examination done, findings were documented. Audiologic evaluation 
done by Tuning fork tests and pure tone audiometry. Pure tone average 
and bone conduction at 4 KHZ recorded. 
Method of Taking Ear Swab for Pus Culture and Sensitivity  
 Under aseptic precautions, ear discharge over tympanic 
membrane issuing from perforation was collected through sterile aural 
speculum thus minimizing external canal contamination by three 
separate sterile cotton wool tipped swab sticks which were then kept in 
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sterile culture tubes. They were immediately transported to 
microbiology laboratory.  
Laboratory Methods 
 Swabs were processed for smear preparation and culture 
inoculation in a laminar flow biosafety hood. 
 A. Direct smear examination 
 Include gram stained smear and wet mount with 10% KOH. 
 Gram stained smears examined for presence of pus cells, 
epithelial cells, gram positive cocci,  gram positive bacilli, and gram 
negative bacilli. 
 KOH smear examined for yeast cells, hyphae, pseydohyphae, and 
spores. 
 B. Culture for aerobic bacteria and their sensitivity patterns. 
 Material from aural swab was inoculated on 
a. Blood agar 
b. Chocolate Agar 
c. Mac Conkey Agar 
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They were incubated at 37° C for 24 – 48 hrs. Any bacterial 
growth which occured was looked for after 24 hrs, and was identified by 
colony characters, microscopic morphology, and biochemical characters 
according to standard protocols.1 
Bacterial sensitivity to various antibiotics as Cefoperazone - 
Sulbactam, Cefotaxime, Amikacin, gentamicin, ofloxacin, ciprofloxacin, 
were assessed by inoculating into Muller- Hinton agar by Kirby – Bauer 
Disk diffusion method.1 
C. Culture for fungus 
Aural swabs were inoculated into 2 tubes of sabouraud's dextrose 
agar one with antibiotic and second with antibiotic and cycloheximide. 
They were incubated at room temperature, Examined thrice weekly for 
first week, and once weekly for next 3 weeks. They were declared 
negative only if no growth occurred after one month. Isolates were 
identified based on colonial, microscopic morphology and biochemical 
characters according to standard protocols.1 
Fungal infection was diagnosed by presence of fungal elements in 
smear examination and growth in culture. Cases which were negative by 
smear examination were nevertheless considered positive for fungus if 
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culture showed heavy confluent growth on both tubes. Anaerobic culture 
was not done due to technical and financial constraints. 
Analysis 
 Results were analyzed for age, sex, unilateral or bilateral clinical 
presentation, otoscopic findings, hearing loss, prevalence of bacterial 
and fungal isolates, and their sensitivity and resistance patterns 
according to standard protocols. 
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OBSERVATIONS 
Table 1 Age and Sex distribution 
Male Female Total Age in 
Years 
Number % Number % Number % 
15-30 28 28% 30 30% 58 58% 
31-45 18 18% 16 16% 34 34% 
36-60 2 2% 4 4% 6 6% 
Above 60 Nil - 2 2% 2 2% 
Total 48  52  100  
 
Table 2 Table showing duration of symptoms 
Duration No. % 
3-6 Months 2 2% 
6 Months – 2Years 21 21% 
More than 2 years 77 77% 
 
Table 3 Symptomatology  
Items Discharge Hard of 
Hearing 
Tinnitus Itching Pain 
Number 100 28 17 16 4 
% 100% 28% 17% 16% 4% 
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Table 4 Table showing audiogram findings 
Age in Year Pure Tone Average  Bone Conduction at  
4 KHz 
15-30 36 21 
31-45 40 21 
45-60 40 20 
Above 60 43 22 
 
Table 5: Culture results 
Items Single infection Mixed infection Sterile 
Number 52 38 10 
% 52% 38% 10% 
 
Pure bacterial 50 50% 
Monomicrobial growth 
Pure fungal 2 2% 
Polymicrobial growth Mixed bacterial 10 10% 
 Bacteria and fungi 28 28% 
Culture sterile Bacteria and fungi 
negative 
10 10% 
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Table 6 Bacterial isolates  
No. Organisms No. % 
1. Pseudomonas aeruginosa 38 38% 
2. Staphylococcus aureus 22 22% 
3. Klebsiella 13 13% 
4. Aceinetobacter 11 11% 
5. Coagulase negative staph  7 7% 
6. Proteus species 5 5% 
7. Escherchia coli 2 2% 
 
Table 6 Fungal isolates  
No. Organisms No. % 
1. Aspergillus flavus 12 40% 
2. Aspergillus niger 6 20% 
3. Candida species  6 20% 
4. Aspergillus fumigatus 3 10% 
5. Aspergillus terreus 2 6.6% 
6. Cladosporium species  1 3.3% 
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Table 7 Antibiotic sensitivity pattern of isolates  
Antibiotic Tested Psudomonas 38 
Staphylococci 
22 
Klebsiella 
13 
Aceinetobacter 
11 
Cons 
7 
Proteus 
5 
Gentamicin No. 25 13 8 2 7 5 
 % 65.7% 59% 61.5% 18.1% 100% 100% 
Amikacin No. 35 21 13 8 7 5 
 % 92.1% 95.4% 100% 72.7% 100% 100% 
Ciprofloxacin No. 30 17 12 8 6 5 
 % 78.9% 77.2% 92.3% 72.7% 85.7% 100% 
Ofloxacin No. 37 20 12 10 7 5 
 % 97.4% 90.9% 92.3% 90.9% 100% 100% 
Cefotaxime No. 12 12 11 2 5 2 
 % 31.5% 54.5% 84.6% 18.1% 71.4% 40% 
Cefoperazone 
Sulbactam 
No. 37 22 13 11 7 5 
 % 97.4% 100% 100% 100% 100% 100% 
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Figure - 1
 Bar Diagram showing age and sex distribution
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Figure - 2 
Pie Chart showing unilateral or bilateral disease
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Figure - 3
 Pie Chart showing duration of illness
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Figure - 4 
 Bar Diagram showing symptomatology
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Figure - 5
 Pie chart showing condition of middle ear mucosa on otoscopy
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Figure- 7
 Pie chart showing breakup bacteriology
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Figure - 8 
Pie Chart showing distribution of fungal species
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Plate No.1 : Normal Tympanic Membrane 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plate No.2 :  Frontal section showing contents of middle ear 
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Plate No.3 :  Right CSOM Anterior 
perforation 
Plate No.4 :  Right CSOM Inferior 
perforation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plate No.5 :  Right CSOM 
Posterior perforation 
Plate No.6 :  Right CSOM 
Antero- Inferior perforation 
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Plate No.7 :  Inactive right 
CSOM. Permanent  defect in 
pars tensa. Normal middle ear 
mucosa. 
Plate No.8 :  Inactive right 
CSOM. Intact long process of 
incus can be seen. 
 
 
 
 
 
 
    
 
Plate No.9 :  Active left CSOM 
Middle ear mucosa inflammed, 
edematons. 
Plate No.10 :  Active left CSOM 
Stapes can be seen through 
perforation. Long process of 
incus eroded. 
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Plate No.11 :  Right CSOM with 
eroded handle of malleus. 
Plate No.12 :  Right CSOM. Sub 
total perforation 
 
 
 
 
 
 
 
 
 
Plate No.13 :  Active left CSOM. Anterior pars tensa defect with 
middle ear mucosa hypertropied forming polyps. 
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Plate No.14 : Scarred pars tensa associated with left healed  
otitis media. 
 
 
 
 
 
Plate No.15 :  Pure tone audiogram - showing mild conductive 
hearing loss right ear. 
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Plate No.16 :  Gram stained 
smear showing gram positive 
cocci in pairs 
Plate No.17 :  Gram stained 
smear showing gram negative 
bacilli amidst of pus cells and 
epithelial cells. 
 
 
 
 
 
         
 
 
Plate No.18 :  Pseudomonas 
aeruginosa colonies on  
Mac Conkey agar. 
Plate No.19 :  Aspergillus flavus 
colonies on sabouraud's agar 
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DISCUSSION 
 Out of the 100 cases studied, age distribution was such that 58% 
of cases in 15-30 years, 34% in 31-45 years, 6% in 46-60 years, and 2 
cases above 60 years. An apparent decrease in incidence as age 
advances can be noted. According to western literature population 
prevalence of adult otitis media does not vary with age.7 A study from 
Benghazi, Libiya23 report age distribution among as 0-15 year- 44.17%; 
15-20 yrs-25%; 3-45 years- 19.17%; 46-60 years- 9.16%; 60 and above 
2.5%. The difference from existing literature in this study may be 
attributed to selection criteria for sample cases, as pediatric age group, 
patients with diabetes mellitus, associated frank otitis externa were 
excluded from study. Also, present study being conducted at a tertiary 
care center, referral patterns may also influence outcome. Large scale 
population studies only can accurately delinate incidence and age 
distributions, particularly for widely prevalent condition as CSOM. 
 Gender distribution shows 1:1 male/ female ratio (48% and 52% 
respectively). It was similar to earlier studies. Obviously CSOM has no 
sex preponderance.  
 Duration of symptoms was more than 2 years in majority of 
patients (77%). An Indian study42 states 64.7% had history of symptoms 
more than one year duration. This typical long standing history of 
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otorrhea has to be seen in accordance with poor living conditions, over 
crowding, nutritional deficiencies and limited access to medical care 
existing in developing countries all contributing to perpetuation of 
disease process. 
 Occurrence of unilateral and bilateral disease was in the ratio of 3: 
1(79% and 21% respectively). Saini S et al30 (2005) reported similar 
figures. (75% and 25% respectively). Urmil Mohan42 (1998) in his 
study at Amritsar observed 86% unilateral and 14% bilateral disease.  
 On analyzing symptomatology, obviously all patients presented 
with otorrhea. Hard of hearing was next predominant symptom (28%) 
Itching was present in 16% cases. Tinnitus in 17%,pain was the least 
mentioned complaint (7 and 4% respectively). B. N. Rao23 (1994) 
reported pain as next common symptom to otorrhea (15%) followed by 
itching, hearing loss and tinnitus 97.5%, 5.8 and 0.8% respectively. 
 Apparent difference may be due to different case selection 
criteria, as for present study small pin hole perforations, pediatric age 
group, associated frank otitis externa, and suspected complications of 
CSOM were excluded. 
 Condition of middle ear mucosa as seen on otoscopy was 54% 
pale and edematous, 39% hyperemic, and 7% granular mucosa. Similar 
findings were observed by Jaya C et al60 
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 On studying audiometry findings, pure tone average was around 
40. Bone conduction at 4 KHz as measure of sensory neural component 
involvement showed no significant sensory neural hearing loss. These 
levels did not vary among age groups. Most of the literature shows there 
is correlation between sensory neural hearing loss and chronic ear 
disease. 65,66,67. 
 Dumich and Harner(1983)68 failed to demonstrate any evidence 
of sensory neural hearing loss in their series of 200 patients.  
 Analysis of culture results showed monomicrobial infection in 
52% (Pure bacterial 50%, pure fungal 2%) polymicrobial (Mixed 
bacteria 10%, Bacterial and Fungal 28%) 38% and Sterile culture on 
10% R.D. Kulakerni  et al (1993)24 in their study reported 62.5%, 7.5% 
and 7.5% respectively. As per Urmil Mohan (1998)42, it was 60.4%, 
6.1%, 25.8%. Sen Gupta et al (1978)39 observed 66.4%, 13.6% and 
8.6%, while in B.N. Rao series23 68.5% were monomicrobial, 32.4% 
were polymicrobial and 10% were sterile cultures. The difference could 
be due to difference in patient population studied and geographic 
variations.  
 Most common organism isolated in present study was 
pseudomonas aeruginosa (38%) followed by staphylococcus aureus 
(22%), Klebsiella (13%), Aceinetobacter (11%), coagulase negative 
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staphylococci (7%), proteus species (5%) and escherechia coli (2%). 
Other studies which observed pseudomonas predomiancne was by  
Fliss DM25 (1992) (Israel), Ashok Mittal (1997-Chaudigarh)32,  
Attalah MS (2001-Saudi Arabia)27 and Aslam MA (2004-Rawalpindi)29 
Studies by B.N. Rao (1994-Libiya)23 and Obi CL. (1995-Nigeria)22 
showed staphylococcal predominance. R. Induharan et al (Malyasia)28 
reported almost equal incidence of pseudomonas (27.2%) and 
staphylococcus aureus (23.6%). 
 A remarkable feature of this study in comparison to studies done 
else where is the increased isolation of Klebsiella (13%) and 
aceinetobacter (11%). Except for Fliss DM25 (8%) all others report only 
2-5% isolation of Klebsiella. They all had higher occurrence of proteus 
upto 15%. 
 In literature, there is reported proven association between climate 
and bacteriology of CSOM. Yildirim A et al (2005)69. Observed that 
when weather is warmed, frequency of isolation of enteric bacteria were 
increased significantly. So, the higher incidence of Klebsiella in this 
study may be positively correlated with comparatively hot humid 
climate of the particular geographic area (Chennai) where the study was 
conducted. 
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 Reported prevalence of aceinetobacter is 4.8% (Ashok Mittal 
1997)32, 1.37% (Beena Antony et al 1996)37 to none. Dadswell J.U.70 
studied on acenetobacter and similar organisms in ear infections. His 
observation was that although these organisms were considered less 
virulent forms few strains can be pathogenic especially once they 
acquire multiple drug resistance. They are ubiquitous in nature, found 
commonly in contaminated water sources. Higher isolation rates in this 
study  may again be attributed to geographical variations and different 
line of antimicrobials routinely used in different parts.  
 Coagulase negative staphylococci was isolated in 7% cases. Even 
though they are generally considered non-pathogenic, their association 
in CSOM cases can be attributed to extreme lowering of resistance in 
middle ear due to invasion by other organisms. Under these 
circumstances, they assume pathogenic role either singly or more often 
in combination with other organism32. 
 Sterile culture was observed in 10 swabs.  
 This can be explained in two ways32 
1. Middle war exudates fail to yield positive results due to presence 
of strictly anaerobic bacteria.  
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2. Presence of viral agents, particularly when the infection was 
caused by respiratory syncitial virus, influenza virus or 
adenovirus.  
Fungal isolates were obtained in 30% cases, 28%, along with 
bacteria and 2% fungi alone. Reported incidence of  secondary fungal 
inspection in other studies are Sen Gupta et al39 25%., Dincer A.D. et al21. 
28.6%, B.N. Rao et al23 7.5%.  Ashok Mittal et al32 40.8%;  
Ibeukwa A.O41 25%; Urmil Mohan42 -13.7%; and Khanna V26-9%. The 
availability and use of broad spectrum antibiotics with or with out 
steroids in period before consultation was probably responsible for 
apparently higher incidence of fungal isolates in the present study.  
A retrospective analysis of Nakagawa et al45 1994 noted frequency of 
isolation of fungi, anaerobic bacteria, and glucose non-fermenting gram 
negative rods were gradually increasing while incidence of proteus 
infections gradually declined over 16 years period (1976-1991). Also 
Martin TJ (2005)44 reports fungal infection are on increasing trend after 
the period of wide spread use of fluroquinolone antibiotics. 
Distribution of fungal species showed Aspigillus flavus (40%), 
Aspergillus niger (20%) Candida (20%), Aspergillus terreus (6.6%) 
Cladosporium species (3.3%). Simialr pattern was observed in three 
other studies26,32,39. But B.N. Rao23 and Urmil Mohan42 reported 
Candida as most common species.  
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Analysis of antibiogram showed majority of pseudomonas, 
staphylococcus aureus, and Klebsiella strains are gaining resistance to 
commonly used antibiotics as gentamicin, cefotaxime and ciprofloxacin. 
They still have marked sensitivities (over 90% of isolates) to amikacin,  
Ofloxacin with around 100% sensitivity to cefoperazone sulbactam. 
Aceinetobacter strains showed multi drug resistant pattern of commonly 
used antibiotics as gentamicin, Amikacin, ciprofloxacin, cefotaxime. 
They were markedly sensitivie to ofloxacin. 
Coagulase negative staphylocci and proteus strains were markedly 
sensitive to all antibiotics except cefotaxime.  
This is  in accordance with recent literature showing high efficacy 
of fluorquinolone antibiotics in treatment of CSOM, especially 
ofloxacin.50,51,52,53,54,56 
Unfortunately for pediatric age group our choice is limited to 
either ototopic fluroquinolones or parentral broad spectrum pencillins or 
aminoglycosides. Pattern of increasing resistance to cefotaxime and 
gentamicin make situation complex. Cefoperazone sulbactam can be 
considered as a  reserve drug in difficult clinical situations, as it attains 
almost 100% sensitivity to all isolates. 
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SUMMARY AND CONCLUSIONS 
1. Gender distribution of CSOM shows no male : female 
preponderance. 
2. Duration of symptoms in more than 77% patients were more 
than 2 years. 
3. Majority of cases were unilateral (79%) 
4. All patients with otorrhea, next common symptom being hard 
of hearing. 
5. Mean pure tone average, was 40, No significant sensory neural 
hearing loss detected among the 100 cases. 
6. Pseudomonas aeruginosa was the most common isolate. 
Klebsiella and aceineto bacter showed an increased incidence of 
13% & 11% in the this study. 
7. 30% cases showed positive results with fungal culture. i.e one 
in 3 patients may have superimposed fungal infections in active 
chronic suppurative otitis media. 
8. Most common fungal isolate was Aspergillus flavus. 
9. Antibiotic with maximum sensitivity to all isolates was 
cefoperazone –sulbactam. Ofloxain and amikacin also showed 
remarkable sensitivities . (more than 90%) to all isolates. Most of 
isolate found to be resistant to commonly used antibiotics as 
cefotaxime, gentamicin. 
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LIMITATIONS OF STUDY 
Despite sincere efforts to minimise pitfalls and draw backs the 
present study has following has following handicaps. 
1. Ideal recommendation for assessing tubotympanic disease and 
culture  sample collection is examination under operating 
microscope, pus being collected by suction aspiration from 
middle ear. It could not be adhered because of obvious practical 
difficulties. 
2. Ideally, culture swab should be taken before starting antibiotics. It 
was not possible, as study was conducted at a tertiary care referral 
center, where most of patients already had treatment with broad 
spectrum antibiotics before consultation, details of which was 
difficult to collect. 
3. Anaerobic culture was not done due to technical and financial 
constraints. 
4. Though sample size was 100, for assessing antibiotic sensitivity 
to each organism separately, number of cases in subclass was too 
small eg:- Total number of proteus isolates among hundred, cases 
was five.  Percentage antibiotic sensitivity pattern of proteus was 
calculated among the five isolates which is statistically 
insignificant. A prospective study with large sample (eg. as 
around 100 isolates of proteus  alone) has its own practical 
constraints with respect to duration. 
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RECOMMENDATIONS 
1. As many bacterial strains implicated in chronic suppurative otitis 
media are gaining resistance to commonly used antibiotics as 
cefotaxime,  gentamicin and even to ciprofloxacin, culture 
directed antibiotic therapy is superior and advisable to empirical 
broad spectrum antibiotic therapy. 
2. In chronic suppurative otitis media 1 in 3 patients can have super 
added fungal infections. So, it is worth while to look for fungi in 
all cases of intractable prolonged otorrhea, not responding to 
antibiotics. 
3. Importance of dry mopping in treatment of CSOM is stressed. 
Dry mopping along with culture directed antibiotic for optimum 
duration, with regular assessment of clinical response to treatment 
is advisable. 
 Indiscriminate use of broad spectrum over-the counter (OTC) 
ototopical preparations with or without steroids for prolonged period is 
to be avoided. 
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PROFORMA 
1. Name   2. Age   3. Sex 
4. Hospital No.  5. Study No. 
6. Presenting symptoms 
 (a) Ear Discharge 
  - Duration (Total) 
  - Frequency 
  - Duration of present episode 
  - Nature of discharge 
  - Quantity  
 (b) Hard of hearing (Yes/ No) 
 (c)  Tinnitus (Yes/ No) 
 (d)  Pain (Yes/No) 
 (e)  Itching (Yes/ No) 
 (f)  Others 
7. Past medical treatment  
 (a) History of Rx for present illness. 
  - Ototopical medications (Yes/ No) - Duration  
        - Medication used 
  - Antibiotic (oral/ inj) (Yes/ No) - Duration 
        - Medication used.  
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8. Past surgical history 
9. Family history  
10. Personal history Smoking (Yes/ No) 
    Over crowding (Yes/ No) 
    History of self cleaning ear (Yes/ No) 
    History of dip baths (Yes/ No) 
11. Socioeconomic status 
12. ENT examination - Ear 
a. External canal – Normal/ inflamed/ excoriations 
b. Discharge- Mucoid/ Mucopurulent / purulent.  
                              Pulsatile/ Non-pulsatile 
                               Profuse/ Scanty  
b. Perforation - Site 
   Size – Medium (   ) Large (   ) Subtotal (    ) 
c. Remnant  TM – Normal/ Congested/ Tympanosclerotic 
patches.  
d. Middle ear mucosa – Hyperemic (   ) pale edematous (   )               
granular 
e. Other findings 
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Nose: positive findings if any 
Throat : positive findings if any 
Final Diagnosis      Audiogram PTA: 
      Bone conduction at 4 KHz 
Ear swab pus c/s Dated:  
Results 
Gram staining 
Bacterial culture and sensitivity  
KOH Smear: 
Fungal Culture: 
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MASTER CHARTS 
 
 
Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
1.  Chellam 27 F O,H >2 B P 36 15 St - G,A,O, Cef, CS Cip 
2.  Mariammal  52 F O >2 U H 38 18 St - G,A,O,Cef, CS Cip 
3.  Rajagopal 41 M O >2 U P 40 20 Cons - G,A,Cip,O,Cef, CS  
4.  Daniel 28 M O,I 1 U P 40 18 A,K AFU 
K-G, A, Cip, O, 
Cef, CS  
A - A,O,CS 
A-G, Cip, 
Cef 
5.  Gajapathy 37 M O >2 U P 38 18 A,K ANi K - G,A,Cip, O,CS A - A.O,CS 
A-G, Cip, 
Cef 
6.  Bakya 32 F O,H,T,I,P >2 B H 38 21 P AFa G,A,Cip,O,Cef, CS Cef 
7.  Arivudia Nambi 45 M O,H,I 8/12 B G 44 21 Cons AFa G,A, Cip, O, Cef, CS  
8.  Parvathi 40 F O 1½ U P 40 20 P AFa G,A,Cip, O, CS Cef 
9.  Thajuden 39 M O >2 U H 42 20 P AFa G,A,Cip, Cef, CS  
10.  Venu 29 M O.H.I >2 U H 30 20 P Ca A, Cip, O, Cs G, Cef 
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Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
11.  Bagaraman 55 M O,H >2 U P 42 22 St Ate G,A,Cef, CS Cip 
12.  Saraswathy 40 F O >2 U H 38 22 E - G,A,Cip, O, CS Cef 
13.  Jayamma 40 F O >2 U H 40 18 E - C,S G,A,O,Cip, Cef 
14.  Kumar 27 M O 1½ U H 32 18 Cons - G,A,O,Cip, Cef, CS  
15.  Rajesh 25 M O,I >2 U P 36 16 St Ani A,O,Cip, Cef, CS G 
16.  Resmi 30 F O,H,I 1 U P 39 20 P,K - G,A,O, Cip, Cef,CS  
17.  Shanmugam 20 M O.I >2 U H 35 18 A AFa A,O,Cip, CS G,Cef 
18.  Thyagu 20 M O,H,T >2 U P 40 18 Pro. AFa G, A,O, Cip,CS Cef 
19.  Shanthi 29 F O >2 U H 36 16 St. - G,A,O,Cip, CS Cef 
20.  Philomina 29 F O >2 U H 32 15 Cons - G,A,O,Cip, Cef, CS  
21.  Poovarasan 15 M O 4/12 U P 33 20 P Clad G,A,O, Cef, CS Cip 
22.  Divya 15 F O,H,T 6/12 U P 40 21 P ANi G,O, Cip,Cef, CS A 
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Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
23.  Vasu 40 M O,H,T 1 B P 42 20 St, K AFa Cip, O,Cef, CS G 
24.  Umapathy 24 M O >2 U H 38 18 A - G,A,Cip, O, CS G,A, Cef 
25.  Devi 30 F O,H 1½ U G 39 19 St - G,A,Cip, O, CS Cef 
26.  Maheswari 25 F O >2 B H 40 21 P,St - G,A,Cip, O, CS Cef 
27.  Dhanalakshmi 19 F O >2 U H 32 15 P - G,A,Cip, O, CS G,Cef 
28.  Amudha 28 F O >2 U H 30 15 St  G,A,Cip, O, CS Cef 
29.  Saravanan 20 M O >2 U P 36 20 St  G,A, Cip, O, CS Cef 
30.  Antony 18 M O 1 U G 35 18 Cons.  G,A,Cip, O, CS Cef 
31.  Anushya 29 F O >2 U P 34 17 Cons. - G,A,Cip, O, CS Cef 
32.  Veketaramani 38 F O.H.T.I,P >2 B P 40 20 K C A,Cef, O,CS G, Cip 
33.  Vijayaraj 38 M O,I,T >2 U H 36 22 - C   
34.  Kantha 65 F O 1½ U H 44 22 P,K C A,Cip, O,CS Cef, G 
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Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
35.  Beegam Bee 56 F O,H,T >2 U P 40 20 Pro.K AFa A, Cip, O, CS Cef, G 
36.  Pankaraj 27 M O 1 U P 38 28 A - Cip, O, CS G,A, Cef 
37.  Sujatha 26 F O >2 U H 36 20 K - G,A, Cip, CS  
38.  Mallika 45 F O >2 U H 44 18 A - Cip, O, Cef, CS G,A, Cef 
39.  Rajamuarugan 25 M O >2 U H 36 16 Pro. - G,A, Cip, O, Cef, CS  
40.  Srinviasan 27 M O.H,T >2 B H 36 15 P - - G,Cip, O, Cef, CS 
41.  Poomadevi 30 F O 1 U P 35 15 St. - Cip, O, Cef, CS G,A 
42.  Deepa 20 F O,I >2 U H 32 18 P C G,O, Cef, CS A,Cip 
43.  Kumari 35 F O 1 U H 34 20 - -   
44.  Lokanathan 36 M O >2 U P 38 18 - - G,A,Cip, O, CS Cef 
45.  Sumathi 29 F O >2 U P 40 20 St. - G,A,Cip, O, CS Cef 
46.  Athiya 35 F O >2 U P 38 22 - - G,A,Cip, O, CS Cef 
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Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
47.  Rajamurugan 18 M O,I,P 1½ U P 30 20 K C A, Cip,O,Cef, CS G 
48.  Damodharan 45 M O >2 U H 40 20 P - G,A,O,Cef,CS Cip 
49.  Antony 37 M O,H,T 8/12 B H 44 22 K - G,A,Cip,Cef,CS O 
50.  Kousalya 24 F O >2 B H 34 21 St, Pro. - G,A,Cip,O,CS Cef 
51.  Rajaraman 45 M 0,H 1 U H 44 18 Cons. - G,A,O,Cef,CS Cip 
52.  Manikandan 15 M 0 >2 B P 34 18 P - G,A,Cip,O,Cef,CS  
53.  Ramalingam 50 M 0,T >2 U H 44 22 P - G,A,Cip,O,Cef,CS  
54.  Kasi 58 M O 1½ U P 46 24 - -   
55.  Rajendran 43 M O,T >2 B P 36 22 A - A,Cef,CS G,Cip,O 
56.  Lalitha 28 F O >2 U H 38 21 P AFa G,A,Cip,O,Cef,CS  
57.  Shanthammal 62 F O.H,T 1 U P 42 22 P - G,A,Cip,O,Cef,CS  
58.  Ramesh 31 M O >2 U P 36 20 P AFa G,A,Cip,O,Cef,CS Cef 
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Antibiotic Sl. 
No. Name Age Sex 
Presenting 
Symptom Duration 
U/L or 
B/L 
Middle Ear 
Mucosa PTA 
Bone con 
at 4KHz Bacteria Fungus Sensitive Resistant 
59.  Abirami 47 F O.H,T >2 B P 40 18 - - G,A,Cip,O,Cef,CS  
60.  Rajendran 40 M O >2 U H 40 22 - - A,Cip,O,CS Cef,G 
61.  Dharani 25 F O >2 U H 35 20 P - A,Cip,O,G,Cef,CS G 
62.  Ravi 25 M O >2 U P 34 20 St - A,O,Cip,CS Cip 
63.  Veketawaran 29 M O >2 U H 40 18 P - G,A,O,Cip,CS G,Cef 
64.  Padma 28 F O,H,T 1 U G 42 18 A - A,Cip,O,Cef,CS Cef 
65.  Parvathi 39 F O >2 U P 40 20 P - G,A,O,Cip,CS G 
66.  Arunkumar 40 M O >2 U H 40 20 P Afa A,Cip,O,Cef,CS G,Cef 
67.  Sengiah 41 M O,H,T,P >2 B H 44 18 St - A,Cip,O,CS Cef 
68.  Karthikeyan 17 M O 1 U G 30 15 K - G,A,Cip,O,CS Cef 
69.  Kavitha 18 F O >2 U H 31 15 P - G,A,Cip,O,CS Cef 
70.  Kuberan 34 M O,H,T >2 B H 42 22 - - G,A,Cip,O,CS  
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71.  Sekhar 33 M O.H >2 B H 44 22 P,K - G,A,O,CS Cef 
72.  Vesanthi 18 F O >2 U H 42 21 P - G,A,O,CS Cip,Cef 
73.  Singaram 34 M O >2 U P 36 20 St - G,A,Cip,O,CS Cef 
74.  Veketeswaran 34 M O >2 U P 38 20 St - A,Cip,O,Cef,CS G 
75.  Kuppan 25 M O,T >2 U H 28 18 P - G,A,Cip,O,CS Cef 
76.  Saravanan 28 M O,I 1 U G 30 15 P AFa G,A,Cip,O,CS Cef 
77.  Lingam 33 M O >2 U P 34 22 A - A,Cip,O,CS G,Cef 
78.  Suban 29 M O,H >2 B H 36 20 P - G,A,Cip,O,CS Cef 
79.  Indira 30 F O >2 U H 40 18 St - G,A,O,Cef,CS Cip 
80.  Jayasree 18 F O >2 U H 36 18 St - G,A,Cip,O,CS Cip 
81.  Sasikala 30 F O >2 U H 34 15 P - A,Cip,O,CS Gen,Cef 
82.  Prema 29 F O,H,I >2 B H 40 20 - AFu   
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83.  Muthumari 23 F O >2 U P 32 20 P - A,Cip,O,CS G,Cef 
84.  Deepika 24 F O >2 U P 38 18 - -   
85.  Soundeswari 38 F O >2 U H 40 20 St ANi A,Cip,O,Cef,CS G 
86.  Sasikumar 28 M O >2 U H 40 20 P - A,O,CS Cef,G,Cip 
87.  Sivakumar 32 M O,I >2 B H 42 22 St  A,Cip,O,Cef,CS G 
88.  Rasi 28 M O,H >2 U P 32 21 St Ate A,Cip,O,Cef,CS G 
89.  Velankanio 30 F O >2 U P 34 18 P - A,O,CS Cef,G,Cip 
90.  Buvaneswari 18 F 0,H >2 B P 36 18 K - G,A,Cip,O,CS Cef 
91.  Laksmi 30 F O >2 U H 32 15 P - GA,Cip,O,CS Cef 
92.  Yamuna 18 F O,H >2 B H 34 16 St - A,Cip,O,Cef,CS G 
93.  Bagya 17 F O,I >2 U H 40 18 P AFu A,Cip,O,Cef,CS G,Cef 
94.  Mohammed 15 M O.H >2 B H 42 20 - -   
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95.  Shanthakumar 34 F O >2 U H 40 20 P A Ni A,Cip,O,G,CS G,Cef 
96.  Priyadarshini 16 F O 1 U G 40 18 P,A - G,A,Cip,O,CS A,Cef 
97.  Kumari 30 F O >2 U P 38 16 Pro - G,A,Cip,O,CS Cef 
98.  Kamala 28 F O.H,I >2 U P 40 16 P A Ni A,O,CS G,Cef,Cip 
99.  Amudhavalli 33 F O >2 U H 42 22 K,A - G,A,Cip,O,CS Cef 
100. Thahira 32 F O >2 U H 36 22 - -   
 
 
